Related by context. All words. (Click for frequent words.) 63 nutlin 3a 63 cisplatin resistant 63 experimentally induced 61 urothelial cancer 61 oncomodulin 60 neurologic progression 60 diabetic mice 60 dyskeratosis congenita 60 biochemical relapse 59 gamma secretase inhibitor 59 p# activation 59 Leydig cells 59 Immunohistochemical analysis 59 flavopiridol 59 elastase 59 recurrent glioblastoma multiforme 59 diabetic rats 59 mutant p# 59 fibrous tangles 59 immunized mice 59 apelin 59 BH4 58 bronchoalveolar lavage fluid 58 prostate carcinoma 58 chemoresistant 58 TP# mutation 58 insulin secreting beta 58 melanoma tumors 58 paricalcitol 58 renal cell carcinomas 58 mice genetically altered 58 stem progenitor cells 58 OGG1 58 transfusion syndrome 58 nicotinamide 58 preterm newborns 58 neoplastic cells 58 fibrin deposition 58 mammary cells 58 Ebstein anomaly 58 posttransplant 58 myeloablative 58 oral clodronate 58 radioiodine therapy 58 mdx mice 58 radiosensitivity 58 acinar cells 57 glioma cells 57 endostatin 57 perioperative complications 57 Ets2 57 transthyretin 57 Inosine 57 cis retinoic acid 57 adjuvant cisplatin 57 alpha1 antitrypsin deficiency 57 insulin secreting cells 57 GBM tumors 57 parathyroid 57 mutated KRAS 57 GIST tumors 57 paclitaxel cisplatin 57 ptau 57 transplanted islets 57 thyroid hormone replacement 57 mice lacking 57 mutated K ras 57 HUCB cells 57 hemolytic 57 CMV infections 57 IGFBP 3 57 interstitial fibrosis 57 Sprague Dawley rats 57 chemo resistant 57 brain lesions 57 melanocyte stimulating hormone 57 ventricular remodeling 57 cranial radiation 57 lung metastases 57 colorectal carcinoma 57 PTEN gene 57 radiolabeled TM# 57 choroid plexus 57 angiosarcoma 57 cancerous nodules 56 Marfan mice 56 trophoblast cells 56 liver metastasis 56 leukaemic cells 56 LRAT 56 resected pancreatic cancer 56 immunoreactivity 56 allogeneic transplants 56 explants 56 NKX2 56 cultured neurons 56 bladder tumors 56 colonic mucosa 56 remyelination 56 hippocampal neurons 56 EGFR TKI 56 prostate cancer metastases 56 ovulatory cycles 56 HepG2 cells 56 neural cells 56 dysgenesis 56 proximal tubules 56 nattokinase 56 phthalate syndrome 56 cholestasis 56 lymphoid cells 56 mammary tumor 56 transgenic rats 56 coagulation parameters 56 vimentin 56 severed spinal cords 56 silibinin 56 telomerase gene 56 colorectal adenoma 56 RYGB surgery 56 recurrent glioblastoma multiforme GBM 56 cisplatin chemotherapy 56 inosine 56 FLT3 ITD 56 MYCN amplification 56 prostate epithelial cells 56 mesangial 56 colorectal adenocarcinoma 56 tumoral 56 peritoneal cancer 56 leucocytes 56 seminomas 56 Neural stem cells 56 pleural fluid 56 nadroparin 56 IDH1 mutation 56 intestinal polyps 56 thymosin 56 pulmonary metastasis 56 thymectomy 56 impair fertility 56 potentiation 56 papillary carcinoma 56 calorically restricted 56 antithymocyte globulin 55 neuroblastoma tumors 55 clonogenic 55 diabetic kidney 55 RAS blockers 55 PC# cells 55 mg kg dose 55 non mutated KRAS 55 adrenal function 55 hepatic fibrosis 55 autologous transplants 55 egg follicles 55 p# deficient 55 postoperative chemotherapy 55 unresectable tumors 55 thymoma 55 Thymic 55 myopathies 55 Endothelial 55 SSc 55 underwent surgical resection 55 mammary tumor formation 55 lung fibrosis 55 thymic carcinoma 55 CTEPH 55 thrombocytosis 55 amyloid deposition 55 cryptogenic 55 Legg Calvé Perthes disease 55 cytogenic 55 PHY# [002] 55 complete cytogenetic response 55 BEXXAR Therapeutic Regimen 55 untreated mice 55 lung metastasis 55 hippocampal neurogenesis 55 male Sprague Dawley 55 pancreatic endocrine 55 motoneurons 55 mitogen activated protein kinases 55 6 OHDA 55 NKT cells 55 axonal degeneration 55 anthracycline chemotherapy 55 induced apoptosis 55 forskolin 55 cranial irradiation 55 TGF ß1 55 hyperplastic 55 benign nodules 55 axonal regeneration 55 genetically reprogrammed 55 hypovolemic 55 atypical neuroleptics 55 intraperitoneal injection 55 precancerous polyp 55 TRAIL induced apoptosis 55 abnormal proteins 55 membranous nephropathy 55 endogenous cannabinoids 55 relapsed MM 55 Hirschsprung disease 55 pancreatic islet 55 circulating lymphocytes 55 ovarian function 55 leukaemic 55 intracerebral 55 mitomycin C 55 mutant KRAS 55 papillary renal cell carcinoma 55 terminally differentiated 55 NMIBC 55 vitro experiments 55 mammary tumors 55 corticosteroid therapy 55 lymphocyte count 55 precancerous condition 55 miglustat 55 Akt1 55 haematopoietic 55 lichen planus 55 Wistar rats 55 achieved CCyR 55 leukemia AML 55 folinic acid 55 imatinib therapy 55 Mesenchymal 55 renal parenchyma 55 bronchoalveolar lavage BAL 55 hMG 55 eotaxin 55 underwent resection 55 MMP# 55 myocyte 55 neuroblastoma cells 55 enlarged spleens 55 lesional 55 weekly subcutaneous injections 55 NAD + 55 submandibular gland 55 receptor inhibitor 55 pancreatectomy 55 alveolar epithelial cells 55 hepatocellular carcinomas 54 nonmalignant 54 postnatally 54 abnormal chromosomes 54 pegylated liposomal doxorubicin 54 leukemic stem cells 54 squamous cell carcinoma SCC 54 haematologic 54 lung fibroblasts 54 TNFa 54 PGE2 54 choriocarcinoma 54 lysophosphatidic acid 54 trophoblastic 54 matrix metalloproteinases 54 Decitabine 54 fruitfly Drosophila 54 teratoma 54 promyelocytic leukemia 54 pancreatic adenocarcinoma 54 siRNA knockdown 54 peritoneal carcinomatosis 54 perioperatively 54 meningeal 54 Histopathologic examination 54 p#NTR 54 receptor blocker 54 streptozotocin 54 erythropoietic 54 TIMP 54 NNRTI resistance 54 pituitary adenomas 54 underwent liver transplantation 54 allogeneic HSCT 54 Gleevec resistant 54 bleomycin 54 ALND 54 dopaminergic neurons 54 EGFRIs 54 splenic 54 tumor recurrence 54 cilengitide 54 immune suppressing 54 glioblastoma tumors 54 malignant lymphoma 54 umbilical vein 54 MPTP 54 prostate tumor 54 detectable HCV RNA 54 myocardial tissue 54 excitotoxic 54 renal tubules 54 chronic granulomatous disease 54 PTEN protein 54 cervical lymph nodes 54 mitochondrial proteins 54 noncancerous cells 54 myo inositol 54 syngeneic 54 Neurofibromatosis type 54 PSADT 54 melanoma lesions 54 Glioblastoma Multiforme GBM 54 acute aortic dissection 54 PPCM 54 aneuploid cells 54 acute myocarditis 54 prothrombotic 54 neurotrophic 54 pretransplant 54 anti nogo 54 androgen ablation 54 bone scintigraphy 54 telomerase activity 54 metastatic lesions 54 metastatic neuroendocrine tumors 54 Paneth cells 54 hepatoma 54 VCUG 54 metabolizing enzyme 54 ZFN modified cells 54 preoperative chemotherapy 54 operable pancreatic cancer 54 neurotrophic factors 54 inducible nitric oxide synthase 54 cultured cells 54 overexpressing 54 esophageal lining 54 pancreatic tissue 54 C EBP alpha 54 Fas ligand 54 ovarian tumors 54 riociguat 54 polycystic kidneys 54 TGF alpha 54 tumor resection 54 hyperoxia 54 pCR 54 micronuclei 54 oxyntomodulin 54 Glioblastoma Multiforme 54 DSAEK 54 unconjugated 54 pancreatic islet cell 54 CD4 + lymphocytes 54 histopathologic examination 54 malignant glioma brain tumor 54 fibrosarcoma 54 hematopoietic cells 54 pulmonary toxicity 54 pancreatic carcinoma 54 myometrium 54 mutant SOD1 54 neuron degeneration 54 chromosomal mutations 54 thrombotic complications 54 TRIM5a 54 fumagillin nanoparticles 54 nerve degeneration 54 transgenic mouse models 54 P. acnes 54 fibroblast cells 54 db db mice 54 myocytes 54 B7 H3 54 stem glioma 54 irinotecan chemotherapy 54 adriamycin 54 Wwox 54 CMV infection 54 familial ALS 54 prostate carcinomas 54 astrocytic 54 suppresses tumor 54 hamartoma 54 bronchopulmonary dysplasia 54 motor neuron degeneration 54 p# mutation 54 cisplatin 54 Circulating tumor cells 54 Adjuvant chemotherapy 54 ovarian hormones 54 p# mutations 54 glioblastoma tumor 54 pancreatitis inflammation 54 cyclosporin 54 haematopoietic stem cell 54 basal cell skin 54 5-fluorouracil/leucovorin 54 pT2 54 K ras mutations 54 periodontal tissue 54 micrometastasis 54 Th2 cytokines 54 chimeric mice 54 Glucocorticoids 54 genetically altered mice 54 neuromotor 53 neurotrophins 53 cerebral vasospasm 53 acinar 53 systemic amyloidosis 53 stem cell engraftment 53 prognostic significance 53 cardiac myocytes 53 oxysterols 53 aromatase inhibitor therapy 53 androgen deprivation 53 malignant neoplasm 53 PTHrP 53 intraventricular 53 intermittent hypoxia 53 survivin expression 53 chromosomal aberrations 53 PSA nadir 53 cystic lesions 53 granule cells 53 microvascular endothelial cells 53 estrogen receptor alpha 53 hamartomas 53 cerebral angiography 53 S#K# 53 monocytic 53 adenomatous 53 liver resection 53 Lodamin 53 inhibited tumor 53 imetelstat 53 underwent coronary angiography 53 suppressor gene 53 Helicobacter infection 53 mutant mice 53 alkalosis 53 DUX4 53 sFlt 1 53 malignant cancerous 53 acetyl L carnitine 53 da maged 53 Belldegrun 53 percutaneous biopsy 53 mesenchymal cells 53 NFATc1 53 TEL AML1 53 VHL gene 53 multiorgan 53 phenothiazines 53 beta subunit 53 RKIP 53 colon carcinoma 53 demonstrated antitumor activity 53 adrenalectomy 53 osteoblastic 53 transplanted bone marrow 53 breast epithelial cells 53 metastatic tumor 53 metastatic malignant 53 overexpress 53 bronchogenic carcinoma 53 uterine tumors 53 pneumonectomy 53 dopaminergic cells 53 luteolin 53 antiestrogen therapy 53 Pdx1 53 SGS# 53 hematopoietic 53 Crizotinib 53 Mitomycin C 53 malignant polyps 53 Estrogen Receptor 53 midgut 53 oxidized lipids 53 CRF receptors 53 dopamine neuron 53 Hurthle cell 53 removed laparoscopically 53 urocortin 53 zebrafish embryo 53 NADPH oxidase 53 engineered bladders 53 ERK1 2 53 E. faecalis 53 chick embryos 53 Kaplan Meier analysis 53 cynomolgus monkeys 53 renal fibrosis 53 chlamydial 53 cerebral ischemia 53 baseline LDH 53 adjuvant radiation 53 malignant ascites 53 locomotor activity 53 LRP5 53 KRAS mutant tumors 53 gastric adenocarcinoma 53 swollen lymph node 53 somatostatin receptors 53 Myelodysplastic Syndrome MDS 53 viral reactivation 53 Ectopia Cordis 53 immunodeficient mice 53 GRNCM1 53 Akt phosphorylation 53 Alu RNA 53 vestibular schwannomas 53 spontaneously hypertensive rats 53 tumorigenicity 53 mutant proteins 53 kallikrein 53 ductal adenocarcinoma 53 pulmonary artery banding 53 hormone angiotensin II 53 anesthetized rats 53 uremic 53 total abdominal hysterectomy 53 neurological dysfunction 53 leptin deficient 53 collagen VII 53 fluoroscopy guided 53 idiopathic thrombocytopenic purpura ITP 53 Tumours 53 preeclamptic 53 retinal degeneration 53 antisense inhibition 53 biliary tract cancer 53 non progressors 53 epigenetic silencing 53 null mice 53 transgenic mice 53 antiproliferative effects 53 cardiac dysfunction 53 CCL# 53 basal cell cancers 53 chorioamnionitis 53 bone marrow derived mesenchymal 53 antitumor effect 53 mutant zebrafish 53 humanized mice 53 ovarian malignancy 53 C#BL 6 mice 53 neoplastic 53 reinfused 53 periodontal tissues 53 TACE 53 prostate cancer PCa 53 Umbilical cord stem cells 53 benign polyps 53 tumor shrinkage 53 liver histology 53 undergoing hysterectomy 53 JAK mutations 53 thyroid nodules 53 osteolytic 53 stathmin gene 53 leptin deficiency 53 orthotopic 53 mouse oocytes 53 TTF Therapy 53 methylation patterns 53 engrafted cells 53 anthracycline therapy 53 carcinoid tumors 53 postoperative complication 53 Or#b 53 tumor nodules 53 lipocalin 53 ovarian carcinoma 53 epigenetically 53 cancer mCRC 53 hyperoxaluria 53 hairless mice 53 acute lymphoblastic 53 Helicobacter 53 TET2 53 p# Shc 53 locoregional recurrence 53 MMP inhibitors 53 autophagic 53 Vasopressin 53 CD8 T cells 53 mucinous 53 activin 53 metastatic gastric 53 aplasia 53 ovariectomized 53 Inhaled nitric oxide 53 tenecteplase 53 bowel polyps 53 lymphoid organs 53 alanine aminotransferase ALT 53 synovial cells 53 inhibit tumor 53 immunodeficient 53 aneuploid 53 lung nodule 53 basiliximab 53 hepatocellular 53 BMPR2 53 microglial 53 pDC 53 KRAS status 53 bile duct cancers 53 S#A# [002] 53 chemo radiotherapy 53 Aortic valve 53 Basal Cell 53 fibroma 53 esophageal gastric 53 stellate cells 53 atherosclerotic lesions 53 glomerular filtration 53 GISTs 53 MeCP2 gene 53 5FU 53 naturally occurring enzyme 53 progression TTP 53 ovariectomy 53 aldose reductase inhibitor 52 T1DM 52 HER2 neu 52 primordial germ cells 52 paraganglioma 52 metastatic lymph nodes 52 gastric carcinoma 52 colon polyp 52 mitoxantrone plus 52 myeloproliferative disorder 52 aP2 52 experimental autoimmune encephalomyelitis 52 cholecystokinin CCK 52 HbF 52 neurotrophin 52 beta1 integrin 52 heterotaxy 52 prostate adenocarcinoma 52 immunosuppressive medication 52 donor marrow 52 CFTR inhibitors 52 cancerdefine 52 Caloric restriction 52 organogenesis 52 inflamed tissues 52 splenocytes 52 FGF2 52 metastatic bladder 52 factor PlGF 52 necrotizing 52 Chronic pancreatitis 52 amyloid β peptide 52 % CI #.#-#.# [003] 52 circadian genes 52 chondrocyte 52 filaggrin 52 pilocytic astrocytoma 52 immunohistochemical staining 52 bone marrow stromal cells 52 cancerous polyp 52 nephrogenic 52 UVB induced 52 trastuzumab Herceptin ® 52 nestin 52 senescent cells 52 enteroviral 52 metabolizer 52 multinucleated 52 clinically detectable 52 neovascularisation 52 Folfox 52 gastrectomy 52 Adjuvant therapy 52 FOLFOX4 52 epididymal 52 epithelial tissues 52 cells cardiomyocytes 52 lymphomas leukemias 52 adipose cells 52 mitochondrial biogenesis 52 chronic myeloid 52 craniectomy 52 androgen suppression 52 follicular lymphomas 52 FOLFOX6 52 bowel resection 52 Untreated mice 52 neurologic deficits 52 Mutant mice 52 Epstein Barr virus EBV 52 mammary gland tumors 52 regenerating tissues 52 hair follicle stem cells 52 GBMs 52 β cell 52 NSCLC tumors 52 recurrent bladder 52 untreated celiac disease 52 Radical prostatectomy 52 neuronal dysfunction 52 Bcl xL 52 infarct size 52 cancerous polyps 52 histologic subtype 52 RSV replication 52 biopsy specimen 52 bioengineered mice 52 Nodules 52 leiomyomas 52 trophic factors 52 lung adenocarcinomas 52 sonographic diagnosis 52 iNO 52 adipose derived stem cells 52 FUS1 52 liver scarring 52 primary cilia 52 neural progenitor cells 52 amyloid deposits 52 bone morphogenic protein 52 urothelial carcinoma 52 occult metastases 52 SIRT6 52 bladder carcinoma 52 retransplantation 52 neurologic outcomes 52 gadolinium enhanced 52 tumor regression 52 C1q 52 EGF receptor 52 malignant transformation 52 carcinoid tumor 52 nNOS 52 nephron 52 visceral metastases 52 hemodialysis patients 52 MGUS 52 radiochemotherapy 52 iPS derived 52 neuroendocrine cancers 52 xenograft tumors 52 parathyroidectomy 52 trophoblasts 52 postsurgery 52 ductal carcinomas 52 acute myeloid 52 blastoma 52 pancreatic ducts 52 adjuvant radiotherapy 52 EXJADE 52 lung tumors 52 Wnt signaling 52 extracapsular extension 52 GRNOPC1 cells 52 tumors 52 CoQ 52 interferon ribavirin 52 PTLD 52 osteopontin 52 salinomycin 52 recurrent metastatic 52 colon tumors 52 preterm neonates 52 cytoreduction 52 chitinase 52 leukocyte count 52 ADAMTS# 52 leptin receptors 52 induced neuropathy 52 SIV infected 52 undetectable PSA 52 ER CHOP 52 calcineurin 52 mutant mice lacking 52 Fluorouracil 52 recurrent glioblastoma 52 LHRH receptor positive 52 Gonadotropin 52 Islet cells 52 neurofibromin 52 PAOD 52 pulmonary fibrosis scarring 52 pamidronate 52 malignant phenotype 52 IL 1beta 52 transplanted kidneys 52 Sertoli cells 52 lymphocytic leukemia 52 skeletal metastases 52 abnormal angiogenesis 52 Partial Response 52 sarcoid 52 phosphorylated tau 52 polyomavirus nephropathy 52 ethosuximide 52 connexin 52 remission CR 52 hematopoietic cell 52 CLL cells 52 neointimal hyperplasia 52 teratogens 52 #.#ng/ml 52 secretes insulin 52 germline mutations 52 colorectal tumors 52 ChR2 52 IUGR 52 undetectable HBV DNA 52 anti Neu5Gc antibodies 52 pig islets 52 liver transplant recipients 52 TGF beta pathway 52 apoptotic pathway 52 Tissue Factor 52 bone marrow stem cells 52 sustained virologic response 52 HNSCC 52 endometrial hyperplasia 52 Gliomas 52 colorectal cancer liver metastases 52 Prostatic 52 vascular endothelial cells 52 dermoid cyst 52 reimplanted 52 induced neuronal 52 basal cell carcinoma BCC 52 noncancerous prostate 52 mesenchymal stem cells MSCs 52 thyrotropin 52 oral squamous cell 52 hyperactivated 52 gene p# 52 parkinsonian symptoms 52 decompensated cirrhosis 52 metastatic adenocarcinoma 52 chemoresistance 52 mesothelial cells 52 melanocyte 52 brachial plexus palsy 52 GLUT4 52 malignant prostate 52 stress hormone corticosterone 52 Hepatocellular Carcinoma HCC 52 HER2 positive cancers 52 neoadjuvant setting 52 Kaplan Meier method 52 ß amyloid 52 mice 52 squamous carcinoma 52 colorectal liver metastases 52 immune modulator 52 molar pregnancy 52 debulking surgery 52 exocrine 52 AGTR1 52 antibiotic minocycline 52 cisplatin gemcitabine 52 retinoic acid 52 Notch1 52 pelvic lymphadenectomy 52 neurocognitive deficits 52 NRG1 52 anterior pituitary 52 induce remission 52 PCNSL 52 primary hyperparathyroidism 52 Hurler syndrome 52 rat pups 52 axillary lymph node dissection 52 lymph node biopsy 52 undetectable virus HCV 52 hyperactivation 52 brain malformation 52 colorectal carcinomas 52 antibody mediated 52 SH2 B 52 CD8 cells 52 xenograft 52 gastric carcinomas 52 hypoxia inducible factor 52 weekly intravenous infusions 52 T1c 52 axillary nodes 52 advanced epithelial ovarian 52 immuno modulatory 52 mutant worms 52 vascular reactivity 52 pancreatic lung 51 pT3 51 MAPCs 51 shortened telomeres 51 necrotizing enterocolitis 51 intestinal mucosa 51 Myelodysplastic Syndrome 51 Notch signaling 51 breast carcinomas 51 diaphragmatic hernia 51 tumor histology 51 KRAS mutations 51 transgene expression 51 IDH2 51 precancerous spots 51 graft dysfunction 51 Treg cells 51 lymphatic vasculature 51 hematologic toxicity 51 mTOR inhibition 51 vitro maturation 51 malignant growths 51 chemoradiotherapy 51 ADPKD 51 Riluzole 51 NPY expression 51 transfected cells 51 heavily pretreated 51 dopamine neurons 51 proteoglycan 51 periostin 51 polypoid 51 operable breast cancer 51 Sjögren syndrome 51 tumor suppressor protein 51 metastatic uveal melanoma 51 endocrine tumors 51 urothelial 51 biochemical recurrence 51 neuronal cell 51 cyclin E 51 Papillary 51 C. pneumoniae 51 myelodysplasia 51 streptococcus infection 51 estramustine 51 Hsp# [001] 51 engraftment 51 K ras gene 51 radiolabeled antibodies 51 Myostatin 51 MyoCell ® 51 griseofulvin 51 pelvic ultrasound 51 SOCS1 51 Cell Lymphoma CTCL 51 Nkx#.# 51 TGF beta1 51 metastatic lung cancer 51 Shp2 51 upregulating 51 urethral stricture 51 pyruvate kinase 51 hypervascular 51 leukaemic stem cells 51 antioxidant supplementation 51 gastrointestinal stromal tumors GISTs 51 mitochondrial mutations 51 RUNX3 51 replicase 51 intravenous cyclophosphamide 51 pancreatic 51 HSCT 51 pancreatic tumor 51 interleukins 51 CD# mAb 51 pancreatic resection 51 fetal echocardiogram 51 astressin B 51 decellularization 51 breast cancer metastasis 51 CD4 + T lymphocytes 51 lumbar disk herniation 51 PPARγ 51 IGF2 51 nodal metastasis 51 Squamous 51 autologous transplantation 51 mitogen 51 periventricular leukomalacia 51 diseased tissues 51 pilocytic astrocytomas 51 stage IIIb IV 51 CR nPR 51 GSTT1 51 antiangiogenic 51 postoperative pulmonary 51 cardiac glycosides 51 hypoperfusion 51 leukemic cells 51 metastasized melanoma 51 nephritis 51 interleukin IL -# 51 fructose diet 51 inherited mutations 51 cirrhotic 51 Malignant glioma 51 neutrophil